Current Technologies and Future Perspectives in Immunotherapy ...

Immunotherapy is now established as a potent therapeutic paradigm engendering antitumor immune response against a wide range of malignancies and other ...

Immunotherapy is now established as a potent therapeutic paradigm engendering antitumor immune response against a wide range of malignancies ...

[PDF] Current Technologies and Future Perspectives in ...

Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach · Shubhamay Adhikary, S. Pathak, +6 authors M. W. Qoronfleh ...

Current Technologies and Future Perspectives in Immunotherapy ...

PDF | Immunotherapy is now established as a potent therapeutic paradigm engendering antitumor immune response against a wide range of ...

Current Perspectives in Cancer Immunotherapy - PMC

Different immunotherapeutic approaches have proved to be of significant clinical value to many patients with different types of advanced cancer.

Immune checkpoint therapy—current perspectives and future ...

Thus, the clinical success with ICT revolutionized the field of cancer immunotherapy and led to ICT becoming a mainstay of cancer therapy along ...

Current Advancements and Future Perspectives of Immunotherapy ...

The advent of immunotherapy has revolutionized the treatment of breast cancer as it utilizes the host's immune system to directly target tumor cells.

Clinical cancer immunotherapy: Current progress and prospects

With the development of sequencing technology and bioinformatics, more and more tumor antigens have been discovered and can be used to distinguish tumor cells ...

Current status and future directions of cancer immunotherapy

Recent years' success of cancer immunotherapy including monoclonal antibodies (mAbs), cancer vaccines, adoptive cancer therapy and the immune checkpoint therapy ...

Current advancements and future perspectives of immunotherapy in ...

Approval of immune checkpoint inhibitor (ICI) for dMMR-MSI-H tumors. In the past, T cell biology has remained in focus in cancer immunotherapy.

The history and advances in cancer immunotherapy - Nature

... immune cells. With recent advances in single-cell technologies such as single-cell RNA sequencing (scRNA-seq) and mass cytometry, systematic ...

Challenges and opportunities in cancer immunotherapy

... new technologies to characterize cancer and antitumor immunity. ... Immune checkpoint therapy-current perspectives and future directions. Cell ...

Current applications and future prospects of nanotechnology in ...

With the development of immunotherapy, cancer treatment will no longer be limited to traditional surgery, chemotherapy, and radiotherapy. Cancer ...

Current Status and Future Perspective of Immunotherapy in ...

Finally, prospects for immunotherapy in the treatment of GI cancers are described. Although only a small proportion of patients with GI cancers ...

Delivery strategies of cancer immunotherapy: recent advances and ...

Immunotherapy has become an emerging strategy for the treatment of cancer. Immunotherapeutic drugs have been increasing for clinical ...

Technological advances in cancer immunity: from immunogenomics ...

... technologies in the field of immunogenomics, single-cell and artificial intelligence, and present prospects for future research.

Immunotherapy for mesothelioma: a critical review of current clinical ...

Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives. ... Technology, Temple University, Philadelphia, PA ...

Future perspectives in cancer immunotherapy - Tsiatas

A large number of ongoing clinical trials involving thousands of patients are currently seeking to define the appropriate tumor type, ...

Future perspectives in cancer immunotherapy | Request PDF

Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach. Article. Full-text available. Jan 2024.

Current Trends and Future Prospects in Immuno-Oncology

Several immunotherapy methods already exist as standard treatments, but many are still limited by adverse events and low efficacy. From ...